U.S., March 18 -- ClinicalTrials.gov registry received information related to the study (NCT06879704) titled 'Radiological Prediction of Response to Neoadjuvant Chemoimmunotherapy for Triple-negative Breast Cancer' on March 10.
Brief Summary: The aim of our study is to find the best imaging technique, alone or in combination, that can best predict a complete response (absence of tumour cells). It also seems important to identify blood markers able to predict which patients will benefit most from treatment, with a view to personalising them, or which patients will be most at risk of toxicities, particularly related to immunotherapy, with a view to personalising monitoring.
Study Start Date: March 21
Study Type: INTERVENTIONAL
Condition: ...